Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
848.91
1,001.39
752.48
1,091.77
1,088.89
1,032.34
874.04
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
848.91
1,001.39
752.48
1,091.77
1,088.89
1,032.34
874.04
Raw Material Cost
256.45
467.90
242.14
513.08
515.74
482.20
375.86
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.49
0.15
1.75
0.45
0.34
0.60
0.79
Selling and Distribution Expenses
378.86
307.80
387.13
300.06
294.62
330.81
291.46
Other Expenses
5.10
6.80
7.66
5.73
5.32
6.50
11.83
Total Expenditure (Excl Depreciation)
687.83
843.83
707.64
870.84
863.91
878.61
786.41
Operating Profit (PBDIT) excl Other Income
161.1
157.6
44.800000000000004
220.9
225
153.7
87.6
Other Income
53.74
6.26
-131.71
4.61
25.35
24.01
31.96
Operating Profit (PBDIT)
249.87
223.09
-45.63
287.36
279.16
230.77
176.63
Interest
1.49
0.15
1.75
0.45
0.34
0.60
0.79
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
592.46
533.49
510.34
578.69
573.15
550.14
498.17
Depreciation
59.28
59.28
61.18
61.18
53.04
53.04
58.11
Profit Before Tax
189.10
163.66
-108.55
225.73
225.78
177.13
117.73
Tax
27.52
19.72
13.39
25.57
33.83
25.61
8.23
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
164.28
143.98
-133.00
190.46
188.60
151.12
91.48
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
164.28
143.98
-133.00
190.46
188.60
151.12
91.48
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-6.35
-5.82
-9.77
4.56
2.56
5.39
-1.32
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
157.93
138.16
-142.77
195.02
191.16
156.52
90.17
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
6,004.12
6,033.71
5,843.50
6,014.14
5,796.50
5,907.07
5,786.12
Earnings per share (EPS)
0.17
0.15
-0.13
0.19
0.19
0.15
0.09
Diluted Earnings per share
0.17
0.15
-0.13
0.19
0.19
0.15
0.09
Operating Profit Margin (Excl OI)
16.12%
15.73%
3.31%
20.29%
18.44%
14.89%
9.9%
Gross Profit Margin
29.26%
22.26%
-6.3%
26.28%
25.61%
22.3%
20.12%
PAT Margin
19.35%
14.38%
-17.68%
17.44%
17.32%
14.64%
10.47%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is -22.04% vs -5.25% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is -17.42% vs 11.36% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is -22.73% vs 11.86% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is 400.00% vs -66.67% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024
Compare Quarterly Results Of Zhejiang Xianju Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
848.91
0
848.91
Other Operating Income
0.00
0.00
0.00
Total Operating income
848.91
0
848.91
Raw Material Cost
256.45
0
256.45
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.49
0
1.49
Selling and Distribution Expenses
378.86
0
378.86
Other Expenses
5.10
0.00
5.10
Total Expenditure (Excl Depreciation)
687.83
0
687.83
Operating Profit (PBDIT) excl Other Income
161.09
0.00
161.09
Other Income
53.74
0
53.74
Operating Profit (PBDIT)
249.87
0
249.87
Interest
1.49
0
1.49
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
592.46
0
592.46
Depreciation
59.28
0
59.28
Profit Before Tax
189.10
0
189.10
Tax
27.52
0
27.52
Provisions and contingencies
0
0
0.00
Profit After Tax
164.28
0
164.28
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
164.28
0
164.28
Share in Profit of Associates
0
0
0.00
Minority Interest
-6.35
0
-6.35
Other related items
0.00
0.00
0.00
Consolidated Net Profit
157.93
0
157.93
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
6,004.12
0
6,004.12
Earnings per share (EPS)
0.17
0
0.17
Diluted Earnings per share
0.17
0
0.17
Operating Profit Margin (Excl OI)
16.12%
0%
0.00
16.12%
Gross Profit Margin
29.26%
0%
0.00
29.26%
PAT Margin
19.35%
0%
0.00
19.35%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 84.89 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is -15.23% vs 33.08% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -22.04% vs -5.25% in Jun 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 15.79 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is 14.25% vs 196.78% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -17.42% vs 11.36% in Jun 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 19.61 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is -9.55% vs 151.80% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -22.73% vs 11.86% in Jun 2024
Quarterly - Interest
Interest 0.15 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is 1,400.00% vs -94.12% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 400.00% vs -66.67% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.12%
in Jun 2025Figures in %
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
